Title |
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing
|
---|---|
Published in |
Diabetologia, June 2013
|
DOI | 10.1007/s00125-013-2962-5 |
Pubmed ID | |
Authors |
S. Ellard, H. Lango Allen, E. De Franco, S. E. Flanagan, G. Hysenaj, K. Colclough, J. A. L. Houghton, M. Shepherd, A. T. Hattersley, M. N. Weedon, R. Caswell |
Abstract |
Current genetic tests for diagnosing monogenic diabetes rely on selection of the appropriate gene for analysis according to the patient's phenotype. Next-generation sequencing enables the simultaneous analysis of multiple genes in a single test. Our aim was to develop a targeted next-generation sequencing assay to detect mutations in all known MODY and neonatal diabetes genes. We selected 29 genes in which mutations have been reported to cause neonatal diabetes, MODY, maternally inherited diabetes and deafness (MIDD) or familial partial lipodystrophy (FPLD). An exon-capture assay was designed to include coding regions and splice sites. A total of 114 patient samples were tested--32 with known mutations and 82 previously tested for MODY (n = 33) or neonatal diabetes (n = 49) but in whom a mutation had not been found. Sequence data were analysed for the presence of base substitutions, small insertions or deletions (indels) and exonic deletions or duplications. In the 32 positive controls we detected all previously identified variants (34 mutations and 36 polymorphisms), including 55 base substitutions, ten small insertions or deletions and five partial/whole gene deletions/duplications. Previously unidentified mutations were found in five patients with MODY (15%) and nine with neonatal diabetes (18%). Most of these patients (12/14) had mutations in genes that had not previously been tested. Our novel targeted next-generation sequencing assay provides a highly sensitive method for simultaneous analysis of all monogenic diabetes genes. This single test can detect mutations previously identified by Sanger sequencing or multiplex ligation-dependent probe amplification dosage analysis. The increased number of genes tested led to a higher mutation detection rate. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Poland | 1 | 17% |
Germany | 1 | 17% |
Netherlands | 1 | 17% |
Chile | 1 | 17% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
Chile | 1 | <1% |
Italy | 1 | <1% |
Brazil | 1 | <1% |
Romania | 1 | <1% |
Unknown | 177 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 33 | 18% |
Student > Ph. D. Student | 30 | 16% |
Student > Master | 25 | 14% |
Student > Bachelor | 17 | 9% |
Student > Doctoral Student | 12 | 7% |
Other | 27 | 15% |
Unknown | 38 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 47 | 26% |
Medicine and Dentistry | 43 | 24% |
Agricultural and Biological Sciences | 26 | 14% |
Nursing and Health Professions | 4 | 2% |
Engineering | 4 | 2% |
Other | 16 | 9% |
Unknown | 42 | 23% |